Table 1 Patient characteristics

Age

   Median

59

   Range

36–73

Male:female

14:2

ECOG performance status

   0

6

37%

   1

8

50%

   2

2

13%

Disease status

   Primary metastatic

12

75%

   Locally-advanced

4

25%

Prior chemotherapy

   Uracil-tegafur

4

25%

   5-FU bolus + folinic acid

1

6%

   5-FU + cisplatin

4

25%

   Epirubicin + cisplatin + capecitabine

5

31%

   Epirubicin + doxorubicin + cisplatin

2

13%